Cargando…

Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells

Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas patients with CF usually develop complete exocrine pancreatic insufficiency, pancreatitis patients with CFTR mutations have mostl...

Descripción completa

Detalles Bibliográficos
Autores principales: Trapp, Simon, Aghdassi, Ali A., Glaubitz, Juliane, Sendler, Matthias, Weiss, Frank Ulrich, Kühn, Jens Peter, Kromrey, Marie‐Luise, Mahajan, Ujjwal M., Pallagi, Petra, Rakonczay, Zoltán, Venglovecz, Viktória, Lerch, Markus M., Hegyi, Peter, Mayerle, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107082/
https://www.ncbi.nlm.nih.gov/pubmed/33682322
http://dx.doi.org/10.1111/jcmm.16404
_version_ 1783689890327691264
author Trapp, Simon
Aghdassi, Ali A.
Glaubitz, Juliane
Sendler, Matthias
Weiss, Frank Ulrich
Kühn, Jens Peter
Kromrey, Marie‐Luise
Mahajan, Ujjwal M.
Pallagi, Petra
Rakonczay, Zoltán
Venglovecz, Viktória
Lerch, Markus M.
Hegyi, Peter
Mayerle, Julia
author_facet Trapp, Simon
Aghdassi, Ali A.
Glaubitz, Juliane
Sendler, Matthias
Weiss, Frank Ulrich
Kühn, Jens Peter
Kromrey, Marie‐Luise
Mahajan, Ujjwal M.
Pallagi, Petra
Rakonczay, Zoltán
Venglovecz, Viktória
Lerch, Markus M.
Hegyi, Peter
Mayerle, Julia
author_sort Trapp, Simon
collection PubMed
description Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas patients with CF usually develop complete exocrine pancreatic insufficiency, pancreatitis patients with CFTR mutations have mostly preserved exocrine pancreatic function. We therefore used a strain of transgenic mice with significant residual CFTR function (CFTR(tm1HGU)) to induce pancreatitis experimentally by serial caerulein injections. Protease activation and necrosis were investigated in isolated acini, disease severity over 24h, pancreatic function by MRI, isolated duct stimulation and faecal chymotrypsin, and leucocyte function by ex vivo lipopolysaccharide (LPS) stimulation. Pancreatic and lung injury were more severe in CFTR(tm1HGU) but intrapancreatic trypsin and serum enzyme activities higher than in wild‐type controls only at 8h, a time interval previously attributed to leucocyte infiltration. CCK‐induced trypsin activation and necrosis in acini from CFTR(tm1HGU) did not differ from controls. Fluid and bicarbonate secretion were greatly impaired, whereas faecal chymotrypsin remained unchanged. LPS stimulation of splenocytes from CFTR(tm1HGU) resulted in increased INF‐γ and IL‐6, but decreased IL‐10 secretion. CFTR mutations that preserve residual pancreatic function significantly increase the severity of experimental pancreatitis—mostly via impairing duct cell function and a shift towards a pro‐inflammatory phenotype, not by rendering acinar cells more susceptible to pathological stimuli.
format Online
Article
Text
id pubmed-8107082
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81070822021-05-10 Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells Trapp, Simon Aghdassi, Ali A. Glaubitz, Juliane Sendler, Matthias Weiss, Frank Ulrich Kühn, Jens Peter Kromrey, Marie‐Luise Mahajan, Ujjwal M. Pallagi, Petra Rakonczay, Zoltán Venglovecz, Viktória Lerch, Markus M. Hegyi, Peter Mayerle, Julia J Cell Mol Med Original Articles Mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR) are an established risk factor for cystic fibrosis (CF) and chronic pancreatitis. Whereas patients with CF usually develop complete exocrine pancreatic insufficiency, pancreatitis patients with CFTR mutations have mostly preserved exocrine pancreatic function. We therefore used a strain of transgenic mice with significant residual CFTR function (CFTR(tm1HGU)) to induce pancreatitis experimentally by serial caerulein injections. Protease activation and necrosis were investigated in isolated acini, disease severity over 24h, pancreatic function by MRI, isolated duct stimulation and faecal chymotrypsin, and leucocyte function by ex vivo lipopolysaccharide (LPS) stimulation. Pancreatic and lung injury were more severe in CFTR(tm1HGU) but intrapancreatic trypsin and serum enzyme activities higher than in wild‐type controls only at 8h, a time interval previously attributed to leucocyte infiltration. CCK‐induced trypsin activation and necrosis in acini from CFTR(tm1HGU) did not differ from controls. Fluid and bicarbonate secretion were greatly impaired, whereas faecal chymotrypsin remained unchanged. LPS stimulation of splenocytes from CFTR(tm1HGU) resulted in increased INF‐γ and IL‐6, but decreased IL‐10 secretion. CFTR mutations that preserve residual pancreatic function significantly increase the severity of experimental pancreatitis—mostly via impairing duct cell function and a shift towards a pro‐inflammatory phenotype, not by rendering acinar cells more susceptible to pathological stimuli. John Wiley and Sons Inc. 2021-03-08 2021-05 /pmc/articles/PMC8107082/ /pubmed/33682322 http://dx.doi.org/10.1111/jcmm.16404 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Trapp, Simon
Aghdassi, Ali A.
Glaubitz, Juliane
Sendler, Matthias
Weiss, Frank Ulrich
Kühn, Jens Peter
Kromrey, Marie‐Luise
Mahajan, Ujjwal M.
Pallagi, Petra
Rakonczay, Zoltán
Venglovecz, Viktória
Lerch, Markus M.
Hegyi, Peter
Mayerle, Julia
Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title_full Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title_fullStr Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title_full_unstemmed Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title_short Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐Not acinar cells
title_sort pancreatitis severity in mice with impaired cftr function but pancreatic sufficiency is mediated via ductal and inflammatory cells‐not acinar cells
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107082/
https://www.ncbi.nlm.nih.gov/pubmed/33682322
http://dx.doi.org/10.1111/jcmm.16404
work_keys_str_mv AT trappsimon pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT aghdassialia pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT glaubitzjuliane pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT sendlermatthias pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT weissfrankulrich pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT kuhnjenspeter pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT kromreymarieluise pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT mahajanujjwalm pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT pallagipetra pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT rakonczayzoltan pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT vengloveczviktoria pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT lerchmarkusm pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT hegyipeter pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells
AT mayerlejulia pancreatitisseverityinmicewithimpairedcftrfunctionbutpancreaticsufficiencyismediatedviaductalandinflammatorycellsnotacinarcells